Fundz

Who to call at Amyris, and when

Fundz watches for the moments Amyris starts buying, and tells you who to reach.

  • An alert the day Amyris raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amyris, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amyris. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Amyris Awarded Agreement from BioMaP-Consortium for $12.3 million to Develop Critical Medicines

Oct 03, 2024

Contract Type

agreement

EmeryvilleManufacturingBiotechnology

Description

Amyris has been awarded an agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) for $12.3 million from the Administration for Strategic Preparedness and Response's (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) to advance innovative pharmaceutical manufacturing in the United States. Amyris aims to develop up to three small molecule drugs over the next two years to address the FDA drug shortage list.

Company Information

Company

Amyris

Location

5885 HOLLIS STREET, SUITE 100

Emeryville, California, United States

About

Amyris is a global leader in renewable biological chemistry, powered by decades of experience and a world-class technology and manufacturing platform. With a proven track record of commercially successful ingredients and building blocks, Amyris has pioneered the use of living systems to convert abundant plant-based sugars into high-performance molecules. Our innovative fermentation-based products serve diverse industries including beauty, advanced materials, food, flavors & fragrances, and beyond, and are found in tens of thousands of products worldwide.

Related People

Sunil
Likely contact at this company
••••••••@••••••••

See Sunil's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Amyris's next move

Learn about Strategic plan

Amyris signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.